The blood-brain barrier (BBB) is a tightly controlled semi-permeable barrier which prevents the paracellular passage for macromolecules and cells from the blood stream into the brain [1] (VaD) brains an altered expression of occludin, a molecular partner of Cls in the TJs structure. Therefore in this study, using an immunohistochemical approach, we investigated the expression of Cl family proteins at detectable levels in all cases studied. We report a significant increase in ratio of neurons expressing 
occludin [5] and the claudin (Cl) family [6] . Occludin and Cls bind to cytoplasmic peripheral membrane proteins, such as ZO-1, ZO-2 or ZO-3, which in turn are connected to the perijunctional actin filament network of the cytoskeleton [1] .
Cls are a 20-28 kD multigene family of transmembrane proteins with different tissue distributions, which have an essential role in the formation of TJs strands, and appear to function as the primary seal of the TJs [7] . Among the Cls expressed by brain endothelial cells, Cl-5 is a critical determinant of BBB permeability [8] . Cl-5 is expressed in all tissues, being specifically localized to the endothelia of blood vessels and therefore TJs containing Cl-5 could regulate the permeability of distal vascular territories [9] . However, Cl-1 [10] and Cl-3 [11] were also shown to localize at the BBB level and their expression seems to be altered by various pathological processes. In addition, Cl-1, Cl-2 and Cl-5 are present in the choroid plexus where their expression is regulated by protein kinase C (PKC) [12] . It was suggested that Cls could function by homo-and hetero-oligomerization and a study which employed RNA interference showed that Cl-2, Cl-4 and Cl-7 are permeation operators for the Na ϩ and Cl Ϫ ions. In contrast to other Cls, Cl-2 decreases the tightness of the TJ strands [13] by formation of cation-selective channels [14] .
Cl-11 is expressed in TJs of myelin sheaths in brain and of Sertoli cells in testis [15] and it is known as well as oligodendrocyte-specific protein, because it represents a major component of central nervous system (CNS)
myelin [16] . Along with other Cl family members, Cl-11 was also found in the epithelial cells of choroid plexus [17] . It was proposed that Cl-11 might be important for the formation and maintenance of myelin and for regulation of oligodendrocytes and Schwann cells proliferation [16] . Considering that the 'sealing' role of TJs is determined by the presence of Cls, the latter is presumably important in pathological situations that involve increased vessel permeability [18] . The integrity of the BBB is compromised in different disorders of the human CNS, most likely by injury or dysregulation of TJs [19] . One example where disruption of BBB is thought to play an important role in the pathophysiology is cerebral microangiopathy [20] . Patients with microangiopathy can present with either isolated or diffuse white matter changes that can ultimately lead to impairment of neuronal flow and cognitive decline, characteristic aspects for most of the dementia disorders [21] . There is mounting evidence that Alzheimer's disease (AD), the most common cause of dementia in the elderly, share vascular risk factors with vascular dementia (VaD) , and at least a third of AD cases associates cerebrovascular small vessel disease [22] . In addition to cerebral amyloid angiopathy, AD subjects show profound changes in cerebral microvessels, often independent of amyloid deposition [23] . Moreover, ␤-amyloid peptide 
Material and methods

Brain material
Quantification of Cl-expressing brain cells
To estimate the number of Cl-expressing neurons, astrocytes and oligodendrocytes we applied two-dimension quantification with random systematic sampling and the unbiased optical fractionator method [34] , similar to a previous study [35] . In brief, the area of interest was delineated in low magnification (ϫ2. 5) (Fig. 4) . 
Results
Expression of claudins in neurons
Expression of claudins in astrocytes
Expression of claudins in cerebral vessels
At the level of brain microvasculature in AD, VaD and control brains we observed that expression of Cls localized selectively in some of the endothelial cells or in the media layer (Fig. 5). The level of expression of Cl-2, Cl-5 and Cl-11 was variable from one vessel to another in all cases studied and no evident qualitative difference between AD, VaD and aged control groups was observed.
Discussion
To our knowledge, this is the first report on different Cl isoforms being expressed in the human brain, not only by endothelial cells and oligodendrocytes, but also by astrocytes and neurons. From
the Cl family of proteins, Cl-1 [10] , Cl-3 [11] and Cl-5 [8] [36] . Expression of Cls in endothelial cells seems to be regulated by both blood stream generated factors, and signals derived from astrocytes and pericytes [37] [38] [39] [40] . Disruption of BBB is now increasingly documented in ageing, vascular and degenerative diseases and this disruption might contribute to the progression of the pathology [1] .
. However, regulation of Cls expression might be operated by different signalling systems in different cell types. Ageing itself decreases expression of Cls and occludin at the level of brain microvessels, altering the BBB permeability
Alteration of the brain microvessels is common to both AD and VaD [42] and chronic brain hypoperfusion as well [43] . A recent report demonstrated that in rats exposed to cerebral hypoperfusion, an up-regulation of Cl-3, which accompanies the BBB breakdown, occurs in endothelial cells [44] . The profile of Cl isoforms expression can be changed by a reduced blood flow not only in the brain, but in other organs as well, such as kidney, where levels of Cl-7 have been found increased in an aging kidney rat model [45] . Ischemia and hypoxia are able to trigger a multitude of cellular responses, including changes in gene expression [46] . [47] .
Our findings of increased level of Cls in neurons and, to some extent, in glial cells as well, might be explained by hypoxia-induced gene regulation. Moreover, as recently suggested for occludin, the increased levels of Cls found in dementia brains might reflect an autophagy of the TJ proteins by neighbouring cells after the BBB breakdown triggered by chronic hypoxia
Several studies indicated a disturbance of function of the hypothalamic-pituitary-adrenocortical (HPA) axis in both AD and VaD, with increased plasma and urinary cortisol levels, as compared to aged controls [48, 49] . Besides increasing the amyloid-␤ and pathology, at least in an AD mouse model [50] and triggering neuronal cell death [51] , glucocorticoids (GC) have been shown to upregulate expression of Cl-5 in murine brain [52] and of other Cl isoforms in cultures from Atlantic Salmon gill [53] . Therefore [54] . A GC-related susceptibility for AD, based on a genetic variation in the GC system, has been reported as well [55] .
We [56] . One recent study [39] [57] and in neuroprotection against excitotoxicity [58] . Therefore, a decrease in VEGF-A availability could explain both the increased Cl-5 expression in neurons in AD and VaD found in this study and the increase in occludin expression, reported before [27] . Furthermore, diminished VEGF activity in brain microvessels was found in areas of AD brains with pathological hallmarks of the disease [59] and VEGF is significantly decreased in serum of AD patients [60] . [61] . TGF-␤ is elevated in plasma [62] and in CSF [63] of AD and VaD patients and its expression is induced following cerebral ischemia with neuroprotective consequences [64] . In addition, TGF-␤ had been found to induce expression of Cl-2 and occludin through activation of ERK/MAPK signalling [65] . Therefore [68] . PKC activation had been reported to down-regulate Cl-2 [12, 69] and to phosphorylate and down-regulate Cl-5, with subsequent alteration of TJs properties [12, 70] . Therefore, the general reduction in PKC activity found in dementia brains could account for the increased levels of Cls found in our study. Moreover, phospholipase D (PLD) expression and activity are up-regulated in AD brains [71] . Phosphatidic acid (PA), a product of PLD, and lysophosphatidic acid (LPA) have been found significantly increased in AD brains as well [72, 73] . PLD and its end-products seem to have multiple links to AD pathogenesis. Although PLD1 colocalizes and interacts with APP [71] and promotes the trafficking and cell surface accumulation of presenilin 1/␥ secretase complex [74] , PLD 2 has been reported to regulate endothelial barrier permeability through cytoskeleton reorganization and occludin down-regulation, in cell culture experiments [75] . LPA, which in contrast to PA [76] has a pro-apoptotic effect on neurons [77] [9] . The expression of Cl-11 in endothelial cells was recently reported in human corpum cavernosum [78] . [79] . Meanwhile, testosterone has been also reported to be an important operator of Cl-11 gene expression, physiological concentrations increasing the amount of Cl-11 mRNA two-to threefold within 3 days in rat Sertoli cells in vitro [80] . However the same study demonstrated that estradiol had no effect on Cl-11 expression. Serum androgen levels are not different in male aged controls and AD patients [81] [82] . LH is also involved in regulation of presenilin 1 and 2 genes [83] , which are the responsible for amyloid processing [84] . LH and FSH could be important players in the pathogenesis of dementia, since their receptors follow a regional pattern of the neuronal populations affected in AD [85] and could operate as well the increased expression of Cl-11 in dementia brains reported in our study.
Transforming growth factor (TGF)-␤ is a member of a family of dimeric polypeptide growth factors involved in cellular differentia
In 
